文章核心观点 - Cigna集团正在通过自动化、分析和人工智能来转型和改善医疗保健的交付方式 [5] - Cigna集团利用这些技术分析数据、发现模式和洞见,以帮助改善结果、增加患者和医疗系统之间的连接性、加快行政流程,并提高整体会员体验 [5] - Cigna集团成立了700万美元的战略企业风险投资基金,投资于在洞见和分析、数字健康和体验以及医疗交付和支持等三个战略领域取得进展的初创公司和成长期公司 [5] 公司概况 - Cigna集团是一家提供综合健康计划和服务的健康服务公司,主要服务包括商业医疗健康计划、政府健康计划以及医疗、行为、药品管理、牙科和视力等专业产品和服务 [3] - Cigna集团通过其国内销售办事处和国外分销商及被许可人提供产品 [3] 创新计划 - Cigna集团于2018年7月推出了行为卓越中心(BCoE),这是一个创新实验室,使Cigna团队能够解决其客户和员工面临的挑战 [4] - BCoE团队与Cigna各业务领导者和商业客户合作,采用数据驱动的方法进行创新,快速向市场推出满足医疗消费者需求的新服务 [4] 技术重点 - Cigna集团利用预测分析、机器学习和深度学习能力创造可操作的洞见,帮助医疗专业人员做出明智的决策 [5] - Cigna集团的数字解决方案将数据贯穿整个医疗服务过程,使个人能够根据个人偏好做出选择 [5] - Cigna集团的技术团队由约9,500名员工和外部合作伙伴组成,支持公司的各种关键信息系统,包括医疗保险理赔系统和专科及邮购药房系统 [5] - Cigna集团的药房技术平台使其能够安全、快速、准确地每年处理超过10亿张调整后的处方 [5] 投资与合作 - Cigna集团成立了700万美元的战略企业风险投资基金,投资于在洞见和分析、数字健康和体验以及医疗交付和支持等三个战略领域取得进展的初创公司和成长期公司 [5] - Cigna集团与多家公司建立了合作关系,包括Virgin Pulse、Amazon Alexa、NIB Holdings、Majesco、FINEOS、Shift Technology等 [7]

Report highlights progress in each of the four pillars underpinning The Cigna Group's ESG framework: Healthy Society, Healthy Workforce, Healthy Environment, and Healthy CompanyBLOOMFIELD, Conn., July 9, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) released its 2023 environmental, social, and governance (ESG) report, detailing the organization's ongoing efforts to strengthen communities and drive improvement to a more sustainable and equitable health care system."The Cigna Group is ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks Style ...

Loading... Loading... Piper Sandler has initiated coverage on Cigna Corporation CI, a diversified managed care and healthcare delivery organization specializing in commercial insurance markets and pharmacy services. The analyst writes, "We believe Cigna has a unique and defensible leadership position in the fast-growing specialty pharmacy market which, together with the company's insurance segment and core PBM business, should support LT-adjusted EPS growth at a 10-14% CAGR." Related: Cigna Crushes Q1 Estim ...

Fundamentally, the case for strong buy healthcare stocks really sells itself. First off, let’s discuss the underlying sector. As I’ve started mentioning recently, wealth without health means nothing. You can reference many spiritual or religious aphorisms that basically state the same thing. Those who gain the entire world ultimately lose it anyways if they forfeit their soul.In other words, the person who perishes with the most toys still perishes. So, fully enjoying the fruit of one’s labor requires havin ...

Members with employer-sponsored insurance saw about a 1% decrease in out-of-pocket costs for their prescription medicines last year, paying an average of $15.10 for a 30-day supplyST. LOUIS, Mo., June 20, 2024  /PRNewswire/ -- Express Scripts, the pharmacy benefits services business of Evernorth, a subsidiary of The Cigna Group (NYSE: CI), today released research spotlighting that members with employer-provided coverage paid less at the pharmacy counter for prescription drugs in 2023 compared to the previou ...

The Cigna Group (CI) continues to be aided by two solid growth platforms, acquisitions and a solid financial position. A solid 2024 guidance also acts as an additional tailwind for the stock. Zacks Rank & Price PerformanceCigna carries a Zacks Rank #3 (Hold), at present.The stock has gained 24% in the past year compared with the industry’s 8% growth. The Medical sector and the S&P 500 composite index have increased 4% and 23.2%, respectively, in the same time frame.Image Source: Zacks Investment ResearchFav ...

会议主要讨论的核心内容 - 公司在2024年第二季度的业务表现基本符合预期,医疗费用率预计将在全年目标范围内 [3][5][6] - 公司在商业雇主业务中看到持续的高使用率,但已经在定价中考虑了这一因素 [5][10] - 公司在个人交易所业务方面进行了一些调整,预计明年将恢复到目标利润区间 [23][25] - Evernorth的专科药业务保持强劲增长,未来有望进一步扩大市场份额 [26][27][29][30] - 公司未来将继续以股票回购为主要的资本部署方式,同时也会审慎考虑适当的并购机会 [38][40] 问答环节重要的提问和回答 问题1 **Nathan Rich 提问** 公司在第二季度的医疗费用率情况如何,是否有任何业务线表现与预期不同 [4] **Brian Evanko 回答** 第二季度的医疗费用率整体符合预期,公司的商业雇主业务和个人交易所业务都在预期范围内 [5][6][8] 问题2 **Nathan Rich 提问** 公司对未来就业环境的预期如何,是否会对公司业务产生影响 [20] **Brian Evanko 回答** 公司目前尚未看到就业市场出现明显的疲软迹象,但考虑到利率持续上升的影响,预计下半年可能会出现一定程度的就业下滑,从而对公司业务产生一定压力 [21] 问题3 **Nathan Rich 提问** 公司在专科药品分销业务方面有哪些增长机会 [33][34] **Brian Evanko 回答** 公司在医疗保险福利下的专科药品分销业务有很大的增长空间,未来将继续加大在这一领域的投入和布局 [34][35][36]

Key Points CI The Cigna Group provides health, dental, vision, accident, pharmacy benefits management, life, homeowners and renters insurance. The Cigna Group saw the writing on the wall with Medicare Advantage (MA) expenses and unloaded its Medicare business for $3.7 billion to Health Care Services Co. While Humana cut its adjusted EPS guidance from $36.00 to a range of $6.00 to $10.00, Cigna beat Q1 2024 EPS by 25 cents and revenues by $660 million and then raised its full-year 2024 EPS guidance. 5 stocks ...

The Cigna Group’s (CI) pharmacy benefits manager, Express Scripts, recently partnered with CPESN USA to enhance access to comprehensive care at independent pharmacies. CPESN USA is a network of pharmacy providers that will help CI in reducing the gaps in care delivery. This move follows guidance from CI’s Independent Pharmacy Advisory Committee.This move is aimed at providing enhanced care services for Medicare members suffering from diabetes and hypertension. One out of five Medicare recipients of 65 years ...